FLGT Q2 Loss and Revenue Miss Cast Doubt on Turnaround Thesis

What happened

Fulgent Genetics reported a Q2 2026 loss of $0.58 per share, significantly worse than the consensus estimate of a $0.46 loss and a reversal from the $0.07 profit a year ago. Revenue also missed estimates, breaking the prior string of improving quarterly trends that underpinned the deep value thesis. The miss directly undercuts the base-case assumption of mid-teens diagnostics growth and margin stabilization above 40%, forcing a reassessment of near-term operating momentum. While the company’s $787.7 million cash cushion remains a key backstop, the earnings disappointment heightens concerns about customer concentration and the sustainability of laboratory services demand. This result repositions the equity closer to a ‘show-me’ story, where the next quarter’s trajectory will be critical to confirming whether the thesis remains intact.

Implication

The Q2 loss and revenue shortfall challenge the core investment case that FLGT could sustain mid-teens growth and improve operating leverage in 2026. The deep value thesis was built on diagnostics momentum and cash-backed downside protection; this report suggests that the turnaround may be stalling. While the balance sheet still offers a floor, the market may now require evidence that Q2 was a one-off before assigning value to the operating business. Investors should monitor FY2026 guidance, any restructuring of the concentrated customer relationship, and whether precision diagnostics growth rebounds above 10%. The $22 attractive entry point is now at risk, and a sustained break below that level would likely shift the risk/reward firmly toward the bear case.

Thesis delta

The Q2 miss and return to a significant operating loss call into question the base-case assumption of mid-teens growth and a return to near-breakeven profitability. The thesis now rests on management’s ability to credibly explain the shortfall as transitory and to reaffirm full-year targets; without that, the probability of the bear case increases materially. Conviction is reduced until the next quarterly report provides clarity.